Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.07 - $1.55 $43,179 - $62,550
-40,355 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.02 - $3.36 $14,119 - $23,486
-6,990 Reduced 14.76%
40,355 $1.15 Million
Q3 2021

Nov 12, 2021

BUY
$2.96 - $36.67 $10,638 - $131,791
3,594 Added 8.21%
47,345 $1.35 Million
Q2 2021

Aug 16, 2021

BUY
$31.5 - $42.5 $1.38 Million - $1.86 Million
43,751 New
43,751 $1.47 Million

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0

About Forte Biosciences, Inc.


  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $114M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.